Secondly, RTI has failed to identify the use of any confidential information of RTI in the manufacture by Zhejiang and supply by CMG of syringes to OMI. Thus, no remedial order lies in the exclusive jurisdiction because any relief is conditioned upon RTI demonstrating use of (or a derived benefit from) RTI's confidential information. ... OMI personnel have toured the Double Dove Shanghai factory. ...   17. Fourthly , clause 2.5 of the OMI contract suggests existing substantial manufacture of retractable syringes. Mr Kiehne says the DMF was provided by CMG to Zhejiang Vitalcare Medical Device Co. Limited ('Zhejiang'). ...   25.